Latest Breaking News On - Emmac life sciences - Page 7 : comparemela.com

  Curaleaf to Enter European Cannabis Market with Acquisition of EMMAC Life Sciences Limited - Europe s Leading Independent Cannabis Company EMMAC Brings the Largest Vertically Integrated Independent Cannabis Company in Europe with a Presence in Key European Medical Cannabis Markets, Including the United Kingdom, Germany, Italy, Spain, and Portugal With the European Population of Nearly 748 Million 1, the Potential Addressable Market is More than Twice the Size of U.S. Market     10 March, London. EMMAC Life Sciences Group, Europe s largest independent cannabis company, is pleased to announce that it is has signed a definitive agreement to be acquired by Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ( Curaleaf or the Company ), a leading U.S. provider of consumer products in cannabis, for a base consideration of approximately US$285 million to be paid in 85%/15% Curaleaf shares and cash. Contingent

United statesUnited kingdomCity ofAntonio costanzoNorton rose fulbrightTracy bradyBoris jordanCuraleaf holdingsUnited nationsMemery crystalLife sciences groupVp corporate communicationsEurope leading independent cannabis companyCuraleaf holdings incStikeman elliottEuropean union